| abstract |
This invention provides for the use of compounds represented by the structure of the general formula (A): n n n n n n n n n n wherein L is a lipid or a phospholipid, Z is either nothing, ethanolamine, serine, inositol, choline, or glycerol, Y is either nothing or a spacer group ranging in length from 2 to 30 atoms, X is a physiologically acceptable monomer, dimer, oligomer, or polymer, wherein X is a glycosaminoglycan; and n is a number from 2 to 1000, wherein any bond between L, Z, Y and X is either an amide or an esoteric bond in treating a subject suffering from a disease associated with harmful angiogenic processes such as cancer. |